Celldex Therapeutics Inc
SWB:TCE2
Celldex Therapeutics Inc
SWB:TCE2
Price:
36.02
EUR
2.24%
Market Closed
Market Cap:
€1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Celldex Therapeutics Inc
SWB:TCE2
|
US |
|
Hermes International SCA
F:HMI
|
FR |
|
E
|
Endeavour Silver Corp
LSE:0R2C
|
CA |
|
B
|
Banco Santander Brasil SA
F:DBSA
|
BR |
|
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
US |
Wall St Price Targets
TCE2 Price Targets Summary
Celldex Therapeutics Inc
Celldex Therapeutics Inc
Wall Street analysts forecast TCE2 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for TCE2 is 50.15 EUR with a low forecast of 32.9 EUR and a high forecast of 90 EUR.
Lowest Forecast
Price Target
32.9
EUR
9% Downside
Average Forecast
Price Target
50.15
EUR
39% Upside
Highest Forecast
Price Target
90
EUR
150% Upside
Celldex Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TCE2's stock price target?
Price Target
50.15
EUR
50.15
EUR
According to Wall Street analysts, the average 1-year price target for TCE2 is 50.15 EUR with a low forecast of 32.9 EUR and a high forecast of 90 EUR.
What is the Revenue forecast for Celldex Therapeutics Inc?
Projected CAGR
147%
147%
Over the last 13 years, the compound annual growth rate for Revenue has been -14%. The projected CAGR for the next 8 years is 147%.
